This nuclear accumulation of PKM2 activates epithelial-mesenchymal transition (EMT) and aerobic glycolysis, enhancing migratory capacity and facilitating the loss of nest-dependent anti-mutagenic properties, particularly in CRC liver metastases. This evidence concerns the gene PKM and colorectal carcinoma.